Dr. Rafeedheen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
201 Park St
Bowling Green, KY 42101Phone+1 270-783-3358Fax+1 270-780-0471
Education & Training
- University of Arkansas for Medical Sciences (UAMS) College of MedicineFellowship, Interventional Cardiology, 2018 - 2019
- SSM Health/Saint Louis University School of MedicineFellowship, Cardiovascular Disease, 2015 - 2018
- Johns Hopkins UniversityResidency, Internal Medicine, 2012 - 2015
- Terna Medical CollegeClass of 2010
Certifications & Licensure
- GA State Medical License 2024 - 2026
- KY State Medical License 2018 - 2025
- AR State Medical License 2018 - 2019
- MO State Medical License 2015 - 2018
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
Publications & Presentations
PubMed
- 1 citationsDelayed-onset eptifibatide-induced thrombocytopenia.Travis Huffman, Evan Gleaves, Glee Lenoir, Rahil Rafeedheen
American Journal of Health-System Pharmacy. 2024-02-08 - 5 citationsReview of pharmacokinetic and pharmacodynamic modeling and safety of proton pump inhibitors and aspirin.Martin G. Gesheff, Christopher J. Franzese, Kevin P. Bliden, Chase J Contino, Rahil Rafeedheen
Expert Review of Clinical Pharmacology. 2014-08-14 - 6 citationsRight ventricular failure following placement of a percutaneous left ventricular assist device.Hassan Alkhawam, Rahil Rafeedheen, Elsayed Abo-Salem
Heart & Lung. 2019-03-01
Abstracts/Posters
- Coronary Artery Disease Severity is a Marker of the Anti-Inflammatory response to Statin TherapyRafeedheen R, Bliden KP, Franzese C, Toth P, Gesheff M, Pandya S, Tantry US, Gurbel PA, Journal of thrombosis and Hemostasis/ International Society on Thrombosis and Haemostasis, Toronto, Canada, 6/10/2015
- Monitoring New Oral Anticoagulants (NOACS) Using New-Generation Thrombelastography TEG®6S SystemBliden KP, Muresan A, Raviv G, Cohen E, Zaman F, Saadin K, Mohammed N, Chaudhary R, Rafeedheen R, Tantry US, Gurbel PA, Journal of thrombosis and Hemostasis/ International Society on Thrombosis and Haemostasis, Toronto, Canada, 6/10/2015
- LDL4 - A Novel Predictor of Coronary Artery Disease SeverityBliden KP, Tantry US, Pandya S, Rafeedheen R, Toth P, Tabrichzi A, Cummings C, Franzese C, Gesheff M, Gurbel PA, Circulation/American Heart Association, Chicago, Illinois, 11/11/2014
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: